Therapy Buckets in Practice: Personalizing Treatment Pathways in Advanced Prostate Cancer
Автор: GU Oncology Now
Загружено: 2025-09-24
Просмотров: 59
A regional roundtable discussion, moderated by Shilpa Gupta, MD, Cleveland Clinic, examined current and emerging strategies in mHSPC and CRPC, including biomarkers and imaging in treatment selection, evolving use of doublet and triplet therapy, ARPI choices and toxicity considerations, and more. Dr. Gupta was joined by other practitioners at Cleveland Clinic, including Christopher Wee, MD; Abdo Haddad, MD; Adriana Alvarez, MD; Moshe Ornstein, MD; and Brian Haines, MD.
In the fourth segment, they weigh the challenges and nuances of sequencing therapies for patients with mCRPC, including the use of PARP inhibitors, chemotherapy, lutetium, and immunotherapy. The panel emphasizes individualized treatment based on genomic mutations, prior therapy responses, and practical considerations in both academic and community settings.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
